NEW YORK – Jumpcode Genomics said on Tuesday that it has raised $21 million in a Series B financing round.
The funding round was co-led by Baird Capital and Arboretum Ventures, and included existing investor LYZZ Capital.
NEW YORK – Jumpcode Genomics said on Tuesday that it has raised $21 million in a Series B financing round.
The funding round was co-led by Baird Capital and Arboretum Ventures, and included existing investor LYZZ Capital.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.